Program
| time | title |
| November 30th | Grand Ballroom A | |||
| 08:00~ | Registration | |||
| 09:20~10:00 | Opening Ceremony | |||
| 10:00~10:40 | Collaborative Innovation at NIIMBL: The National Institute for Innovation in Manufacturing Biopharmaceuticals - Kelvin H. Lee (Director, NIIMBL) |
|||
| 10:40~11:20 | Cell Culture Engineering: The Key to Global Competitiveness of the K-Biopharma Industry - Gyun Min Lee (Professor, KAIST) |
|||
| 11:20~12:00 | Manufacturing Challenges for Biologics Production in Manufacturing Technology Association of Biologics (MAB), JAPAN - Takeshi Omasa (Professor, Osaka University, Japan) |
|||
| Grand Ballroom A | Room 206 + 207 | |||
| 13:00~15:00 | Session 1 Biopharmaceuticals #1 Infectious Disease &Vaccine |
Session 2 Foods & Medicine (in conjunction with KFOB) |
||
| <organizer>- Yeong Ok Baik (CEO, EuBiologics Co., Ltd, Korea) | <organizer>- Cheon-Seok Park (Professor, Kyung Hee University, Korea) | |||
| <chairs>- Jong Youn Baik (Professor, Inha University, Korea) - Seung Hyun Han (Professor, Seoul National University, Korea) |
<chairs>- Ji-Yeon Kim (Professor, Seoul National University, Korea) - Hak-Dong Shin (Professor, Sejong University, Korea) |
|||
| <speakers>- Seung Hyun Han (Professor, Seoul National University, Korea) - Kang Chang Yuil (CEO, Cellid, Korea) - Kee-Jong Hong (Director General, Korea mRNA Vaccine initiative (KmVAC) / Professor, Gachon University, Korea) - Jonathan Lovell (CEO, POP Biotechnologies / Professor, State University of New York at Buffalo, USA) |
<speakers>- Kee-Hong Kim (Professor, Purdue University, USA) - Ji-Young Lee (Professor, University of Connecticut, USA) - Sunjae Lee (Professor, GIST, Korea) - Sungho Won (Professor, Seoul National University, Korea) |
|||
| 15:30~17:30 | Session 3 Biopharmaceuticals #2 Gene & Cell Therapeutics |
Session 4 Bio HUB (AFOB Workshop) |
||
| <organizer>- Seungshin Yu (CTO, Helixmith, Korea) - Hyun Jin Kim (Professor, Inha University, Korea) |
<organizer>- Beom-seop Rho (Director, Incheon Technopark(ITP), Korea) - Yun Suk Huh (Professor, Inha University, Korea) |
|||
| <chairs>- Hyun Jin Kim (Professor, Inha University, Korea) | <chairs>- Won Jong Rhee (Professor, Incheon National University, Korea) - Tae-Joon Jeon (Professor, Inha University, Korea) |
|||
| <speakers>- Sangsu Bae (Professor, Seoul National University, Korea) - Kye Il Joo (Professor, Ewha Womans University, Korea) - Yongjin Choi (Director, Epibiotech, Korea) - Horacio Cabral (Professor, University of Tokyo, Japan) |
<speakers>- Iljin Jang (Team Leader, Incheon Metropolitan City, Korea) - Beom-seop Rho (Director, Incheon Technopark(ITP), Korea) - Won Jong Rhee (Professor, Incheon National University, Korea) - Daeeui Hong (CEO, Mondrian AI, Korea) - Yun Suk Huh (Professor, Inha University, Korea) |
|||
| December 1st | Grand Ballroom A | Room 206 + 207 | ||
| 10:00~12:00 | Session 5 Biopharmaceuticals #3 Protein & Antibody Therapeutics |
Session 6 Biopharmaceuticals #4 Current Policy, Regulation, Economy, Industry, Investment for Biopharmaceuticals |
||
| <organizer>- Inchan Kwon (Professor, GIST, Korea) | <organizer>- Minsik Park (Chief Investment Officer, STIC Ventures, Inc., Korea) | |||
| <chairs>- Inchan Kwon (Professor, GIST, Korea) | <chairs>- Minsik Park (Chief Investment Officer, STIC Ventures, Inc., Korea) | |||
| <speakers>- Yong-Sung Kim (Professor, Ajou University, Korea) - Sang Gyu Park (CEO, Novelty Nobility / Professor, Ajou University, Korea) - Sang Hyun Moh (CEO, BIO-FD&C / Professor, Chung-Ang University, Korea) - Dae-Hyuk Kweon (CTO, MVRIX / Professor, Sungkyunkwan University, Korea) |
<speakers>- MyoungHee Kim (Senior Director, IQVIA Korea, Korea) - Keunhee Seo (Analyst, Samsung Securities, Korea) - Myung Kee Kim (CEO, LSK investment, Korea) - Hyung Chul Kim (PD, KEIT, Korea) |
|||
